TABLE 1.
Patient clinical and biochemical characteristics.
| Characteristics | Total (n = 41) | DKD non-ESRD group (n = 22) | DKD ESRD group (n = 19) |
|---|---|---|---|
| Male, n. (%) | 27 (65.85%) | 16 (72.73%) | 11 (57.89%) |
| Age (years) | 65.39 ± 11.38 | 69.63 ± 13.01 | 61.89 ± 9.85 |
| Blood pressures (mmHg) | |||
| Systolic | 158.49 ± 22.36 | 160.90 ± 21.98 | 156.00 ± 23.48 |
| Diastolic | 82.63 ± 11.91 | 84.22 ± 13.1 | 79.47 ± 10.16 |
| SCr (µmol/L) | 372.90 ± 232.59 | 189.70 ± 74.64* | 577.02 ± 164.35 |
| eGFR (ml/min/1.73 m2) | 22.91 ± 18.81 | 36.01 ± 16.77* | 7.78 ± 2.37 |
| 24hU-pro (g/24 h) (IQR) | 3.82 (1.38, 5.16) | 3.00 (0.95, 5.7) | 3.83 (1.94, 5.01) |
| HbA1c (%) | 6.40 (5.56, 7.45) | 6.90 (5.70, 7.60) | 5.85 (5.38, 7.10) |
| UA (µmol/L) (IQR) | 476.50 (370.00, 574.00) | 451.00 (357.50, 574.00) | 508.00 (434.00, 587.00) |
| BUN (mmol/L) (IQR) | 17.70 (11.01, 24.47) | 11.23 (8.36, 13.52)* | 23.47 (20.48, 29.98) |
| Triglycerides (mmol/L) (IQR) | 1.75 (1.16, 2.37) | 1.63 (0.88, 2.03) | 2.11 (1.42, 2.62) |
| Cholesterol (mmol/L) | 5.18 ± 1.77 | 5.34 ± 1.82 | 4.97 ± 1.86 |
| HDL (mmol/L) | 1.13 ± 0.35 | 1.33 ± 0.59 | 1.03 ± 0.35 |
| LDL (mmol/L) | 3.42 ± 1.60 | 3.66 ± 1.71 | 3.13 ± 1.50 |
| Serum albumin (g/L) | 35.23 ± 5.65 | 34.44 ± 6.72 | 36.10 ± 3.84 |
| AST (U/L) (IQR) | 16.00 (13.00, 20.00) | 17.00 (13.00, 21.00) | 16.00 (11.00, 20.50) |
| ALT (U/L) (IQR) | 12.00 (9.00, 21.00) | 14.00 (10.75, 21.25) | 9.00 (7.00, 16.00) |
Note. Abbreviations: SCr, serum creatinine; eGFR, estimated glomerular filtration rate; 24hU-pro, 24-h urinary protein quantity; UA, uric acid; BUN, blood urea nitrogen; LDL, low-density lipoprotein; HDL, high-density lipoprotein; AST, glutamic oxaloacetic transaminase; ALT, alanine aminotransferase; IQR, interquartile range; DKD, diabetic kidney disease; ESRD, end-stage renal disease.
*p < 0.05 vs. DKD ESRD group.